Open AccessScreening and Study Enrolment in the Randomized Evaluation of Normal vs. Augmented Level (RENAL) Replacement Therapy Trial
Author(s) -
Rinaldo Bellomo,
Alan Cass,
Louise Cole,
Simon Finfer,
Martin Gallagher,
Donna Goldsmith,
John Myburgh,
Robyn Norton,
Carlos Scheinkestel,
Ashoke Banarjee Deepak Bhonagiri,
David Blythe,
John Botha,
J. R. Cade,
Geoff Dobb,
John Eddington,
Arthas Flabouris,
Craig French,
Peter Garrett,
Seton Henderson,
Benno U. Ihle,
Chris Joyce,
Michael Kalkoff,
Jeffrey Lipman,
Colin McArthur,
Shay McGinness,
David Milliss,
Imogen Mitchell,
John M. Morgan,
P. V. Nair,
Neil Orford,
Asif Raza,
Yahya Shehabi,
Antony Tobin,
Richard Totaro,
Andrew Turner,
Cassandra Wright
Publication year - 2009
Publication title -
blood purification
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.686
H-Index - 57
eISSN - 1421-9735
pISSN - 0253-5068
DOI - 10.1159/000195091
Subject(s) - medicine , renal replacement therapy , randomized controlled trial , observational study , dialysis , inclusion and exclusion criteria , clinical trial , intensive care medicine , informed consent , intensive care , physical therapy , alternative medicine , pathology
Aspects of trial design, screening and study efficiency can affect recruitment and the findings of the trial itself. A clear understanding of the screening and study inclusion process will assist clinicians in interpreting trial results.